Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC35326106201;106202;106203 chr2:178530639;178530638;178530637chr2:179395366;179395365;179395364
N2AB33685101278;101279;101280 chr2:178530639;178530638;178530637chr2:179395366;179395365;179395364
N2A3275898497;98498;98499 chr2:178530639;178530638;178530637chr2:179395366;179395365;179395364
N2B2626179006;79007;79008 chr2:178530639;178530638;178530637chr2:179395366;179395365;179395364
Novex-12638679381;79382;79383 chr2:178530639;178530638;178530637chr2:179395366;179395365;179395364
Novex-22645379582;79583;79584 chr2:178530639;178530638;178530637chr2:179395366;179395365;179395364
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Ig-165
  • Domain position: 41
  • Structural Position: 58
  • Q(SASA): 0.1314
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/P None None 1.0 D 0.862 0.81 0.767735741357 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.9041 likely_pathogenic 0.8743 pathogenic -1.946 Destabilizing 0.998 D 0.573 neutral None None None None N
L/C 0.9383 likely_pathogenic 0.9172 pathogenic -1.072 Destabilizing 1.0 D 0.777 deleterious None None None None N
L/D 0.9973 likely_pathogenic 0.9955 pathogenic -1.967 Destabilizing 1.0 D 0.857 deleterious None None None None N
L/E 0.9687 likely_pathogenic 0.9547 pathogenic -1.726 Destabilizing 1.0 D 0.857 deleterious None None None None N
L/F 0.6989 likely_pathogenic 0.5939 pathogenic -1.207 Destabilizing 1.0 D 0.737 prob.delet. None None None None N
L/G 0.9797 likely_pathogenic 0.9698 pathogenic -2.432 Highly Destabilizing 1.0 D 0.84 deleterious None None None None N
L/H 0.9641 likely_pathogenic 0.9408 pathogenic -1.75 Destabilizing 1.0 D 0.849 deleterious None None None None N
L/I 0.1825 likely_benign 0.1629 benign -0.535 Destabilizing 0.813 D 0.318 neutral None None None None N
L/K 0.9604 likely_pathogenic 0.9438 pathogenic -1.258 Destabilizing 1.0 D 0.817 deleterious None None None None N
L/M 0.3379 likely_benign 0.2887 benign -0.506 Destabilizing 0.999 D 0.773 deleterious N 0.506454654 None None N
L/N 0.9818 likely_pathogenic 0.9722 pathogenic -1.707 Destabilizing 1.0 D 0.861 deleterious None None None None N
L/P 0.9768 likely_pathogenic 0.9649 pathogenic -0.989 Destabilizing 1.0 D 0.862 deleterious D 0.543677122 None None N
L/Q 0.9105 likely_pathogenic 0.8741 pathogenic -1.496 Destabilizing 1.0 D 0.839 deleterious D 0.543930612 None None N
L/R 0.9349 likely_pathogenic 0.9103 pathogenic -1.218 Destabilizing 1.0 D 0.845 deleterious D 0.543677122 None None N
L/S 0.9817 likely_pathogenic 0.9703 pathogenic -2.355 Highly Destabilizing 1.0 D 0.797 deleterious None None None None N
L/T 0.9237 likely_pathogenic 0.8934 pathogenic -1.959 Destabilizing 1.0 D 0.741 deleterious None None None None N
L/V 0.2709 likely_benign 0.2449 benign -0.989 Destabilizing 0.981 D 0.489 neutral D 0.524058846 None None N
L/W 0.9055 likely_pathogenic 0.8529 pathogenic -1.462 Destabilizing 1.0 D 0.791 deleterious None None None None N
L/Y 0.9434 likely_pathogenic 0.909 pathogenic -1.134 Destabilizing 1.0 D 0.83 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.